A. Hartmann et al., PERSISTING EFFECT OF CA2-CHANNEL BLOCKERS ON LEFT-VENTRICULAR FUNCTION IN HYPERTROPHIC CARDIOMYOPATHY AFTER 14 YEARS TREATMENT(), Angiology, 47(8), 1996, pp. 765-773
Ca2+-channel blockers of the verapamil type have been reported to exer
t a beneficial effect on clinical. symptoms and survival rates in hype
rtrophic cardiomyopathy, The effects of verapamil have been attributed
predominantly to an improved diastolic filling. It is unknown whether
an effect on diastolic filling persists in these patients after long-
term treatment. Fourteen patients (12 men, 2 women, median age fifty-o
ne [thirty-two to fifty-five] years) with hypertrophic cardiomyopathy
were included in the study, Patients had been treated with verapamil 2
40-480 mg/d or gallopamil. 150-200 mg/d for fourteen (seven to sevente
en) years. The effect of a withdrawal of Ca2+-channel blockers on para
meters of left ventricular diastolic function was evaluated at rest an
d during exercise in patients with hypertrophic cardiomyopathy after l
ong-term therapy. Investigations were performed at rest and during sup
ine ergometric exercise during ongoing Ca2+-channel blocking therapy a
nd after five (four to nine) days' withdrawal (control). Pulsed Dopple
r echocardiography was used to record diastolic mitral flow profiles f
rom an apical four-chamber view. Withdrawal of Ca2+-channel blockers o
f the phenylalkylamine type after long-term treatment of hypertrophic
cardiomyopathy resulted in a significant reduction of early diastolic
inflow velocity at rest and during exercise. In conclusion, these resu
lts indicate a persistent improvement of early diastolic filling by Ca
2+-channel blockers even after long-term treatment.